CogState signs $400,000 functional food deal
Monday, 13 February, 2006
CogState (ASX:CGS) is to provide cognition testing services to a European food products company in a contract worth more than AUD$400,000.
Over the next 12 to 15 months, Cogstate will be studying the effect of the European company's dietary product on cognitive function in a trial conducted at the Murdoch Children's Research Institute, Melbourne.
If the trial demonstrates cognitive function enhancement as a result of people consuming its dietary supplement, the food products company will be able to make marketing claims in relation to the product.
Link between oestrogen and heart health found in women
Scientists found that oestrogen helps increase the ANXA1 protein, and when ANXA1 is missing, the...
Frequent nightmares accelerate aging, increase risk of death
Nghtmares independently predict faster biological aging and earlier mortality — even after...
Cardiac organoids bring hope for treating heart disease
Australian scientists have developed lab-grown, three-dimensional heart tissues known as cardiac...
